Categories Earnings, Technology

FireEye quarterly results beat estimates

FireEye (FEYE) reported a wider loss for the second quarter due to an increase in operating expenses. The top and bottom line came in above analysts’ expectations. Shares of the cybersecurity company fell more than 4% in the aftermarket session due to stable full-year forecast.

Net loss attributable to common stockholders widened to $72.9 million from $68.34 million a year ago, while loss per share narrowed to $0.38 from $0.39 due to higher weighted average shares. Non-GAAP results turned to breakeven per share from a loss of $0.03 per share.

Revenue increased 6% to $203 million. Sales growth was broad-based across all geographies and product families, and demand for its differentiated security products and services is increasing as it enters the second half of 2018.

FireEye second quarter 2018 earnings

The company’s billings, one of the key indicators for future growth, jumped 13% year-over-year to $196 million. This is the second time billings has risen after a slowdown in billings had troubled the company for many quarters. Billings narrowly beat the forecast of $180 million to $195 million.

Looking ahead into the third quarter, the company predicts total revenue of $206 million to $210 million, billings of $210 million to $220 million, and non-GAAP EPS of $0.01-0.03.

For the full year 2018, the company still expects revenue of $820 million to $830 million, billings of $825 million to $845 million, and non-GAAP EPS of $0.00-$0.04. Capital expenditures are still predicted to be $40 million to $45 million.

Shares of FireEye ended Wednesday’s regular trading session up 1.03% at $15.69 on the Nasdaq. The stock has risen more than 10% for the year-to-date and more than 6% for the past year.

Related Infographics: Q1 Earnings

FireEye Q1 2018 Earnings

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top